Radiation-Dose-Lowering Effect of Landiolol Hydrochloride in Coronary Angiography Using Computed Tomography: A Prospective Multicentre Study

Trial Profile

Radiation-Dose-Lowering Effect of Landiolol Hydrochloride in Coronary Angiography Using Computed Tomography: A Prospective Multicentre Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 May 2016

At a glance

  • Drugs Landiolol (Primary)
  • Indications Ischaemic heart disorders
  • Focus Therapeutic Use
  • Acronyms DELIGHT
  • Most Recent Events

    • 28 Mar 2016 Status changed from active, no longer recruiting to completed, according to the results published.
    • 28 Mar 2016 Primary endpoint has been met, according to the results published.
    • 28 Mar 2016 Results (n=219) published in the Circulation Journal.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top